- Report
- November 2025
- 381 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 285 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 386 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 474 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 140 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 207 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 281 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 380 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 288 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 138 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 362 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 364 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 290 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 464 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 172 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 476 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more